Computational Systems Biology Methods and Protocols.7z

(nextflipdebug5) #1

  1. Tosello V et al (2009) WT1 mutations in
    T-all. Blood 114(5):1038–1045

  2. Xavier RJ, Rioux JD (2008) Genome-wide
    association studies: a new window into
    immune-mediated diseases. Nat Rev Immu-
    nol 8(8):631–643

  3. Sherborne AL et al (2010) Variation in
    CDKN2A at 9p21.3 influences childhood
    acute lymphoblastic leukemia risk. Nat Genet
    42(6):492–494

  4. Perez-Andreu V et al (2013) Inherited
    GATA3 variants are associated with Ph-like
    childhood acute lymphoblastic leukemia and
    risk of relapse. Nat Genet 45(12):1494–1498

  5. Papaemmanuil E et al (2009) Loci on 7p12.2,
    10q21.2 and 14q11.2 are associated with risk
    of childhood acute lymphoblastic leukemia.
    Nat Genet 41(9):1006–1010

  6. Xu H et al (2015) Inherited coding variants at
    the CDKN2A locus influence susceptibility to
    acute lymphoblastic leukaemia in children.
    Nat Commun 6:7553

  7. Perez-Andreu V et al (2015) A genome-wide
    association study of susceptibility to acute
    lymphoblastic leukemia in adolescents and
    young adults. Blood 125(4):680–686

  8. Liao F et al (2016) Association between
    PIP4K2A polymorphisms and acute lympho-
    blastic leukemia susceptibility. Medicine (Bal-
    timore) 95(18):e3542

  9. Xu H et al (2012) ARID5B genetic poly-
    morphisms contribute to racial disparities in
    the incidence and treatment outcome of
    childhood acute lymphoblastic leukemia. J
    Clin Oncol 30(7):751–757

  10. Linabery AM, Ross JA (2008) Trends in
    childhood cancer incidence in the
    U.S. (1992–2004). Cancer 112(2):416–432

  11. Dores GM et al (2012) Acute leukemia inci-
    dence and patient survival among children
    and adults in the United States, 2001–2007.
    Blood 119(1):34–43

  12. Burmeister Tet al (2014) Germline variants in
    IKZF1, ARID5B, and CEBPE as risk factors
    for adult-onset acute lymphoblastic leukemia:
    an analysis from the GMALL study group.
    Haematologica 99(2):e23–e25

  13. Hou Q et al (2017) Regulatory network of
    GATA3 in pediatric acute lymphoblastic leu-
    kemia. Oncotarget 8(22):36040–36053

  14. Trevino LR et al (2009) Germline genomic
    variants associated with childhood acute lym-
    phoblastic leukemia. Nat Genet 41
    (9):1001–1005

  15. Huang Q (2015) Genetic study of complex
    diseases in the post-GWAS era. J Genet Geno-
    mics 42(3):87–98

  16. Freedman ML et al (2011) Principles for the
    post-GWAS functional characterization of
    cancer risk loci. Nat Genet 43(6):513–518

  17. Vijayakrishnan J et al (2015) The 9p21.3 risk
    of childhood acute lymphoblastic leukaemia is
    explained by a rare high-impact variant in
    CDKN2A. Sci Rep 5:15065

  18. Walsh KM et al (2015) A heritable missense
    polymorphism in CDKN2A confers strong
    risk of childhood acute lymphoblastic leuke-
    mia and is preferentially selected during clonal
    evolution. Cancer Res 75(22):4884–4894

  19. Studd JB et al (2017) Genetic and regulatory
    mechanism of susceptibility to high-
    hyperdiploid acute lymphoblastic leukaemia
    at 10p21.2. Nat Commun 8:14616

  20. Hungate EA et al (2016) A variant at 9p21.3
    functionally implicates CDKN2B in paediatric
    B-cell precursor acute lymphoblastic leukae-
    mia aetiology. Nat Commun 7:10635

  21. Yin D et al (2017) Impact of NUDT15 poly-
    morphisms on thiopurines-induced myelo-
    toxicity and thiopurines tolerance dose.
    Oncotarget 8(8):13575–13585

  22. Yang JJ et al (2015) Inherited NUDT15 vari-
    ant is a genetic determinant of mercaptopu-
    rine intolerance in children with acute
    lymphoblastic leukemia. J Clin Oncol 33
    (11):1235–1242

  23. Moriyama T et al (2016) NUDT15 poly-
    morphisms alter thiopurine metabolism and
    hematopoietic toxicity. Nat Genet 48
    (4):367–373

  24. Xu H et al (2015) Common variants in
    ACYP2 influence susceptibility to cisplatin-
    induced hearing loss. Nat Genet 47
    (3):263–266

  25. Martinelli G et al (2009) IKZF1 (Ikaros)
    deletions in BCR-ABL1-positive acute lym-
    phoblastic leukemia are associated with short
    disease-free survival and high rate of cumula-
    tive incidence of relapse: a GIMEMA AL WP
    report. J Clin Oncol 27(31):5202–5207

  26. Schwab C et al (2010) Evaluation of multi-
    plex ligation-dependent probe amplification
    as a method for the detection of copy number
    abnormalities in B-cell precursor acute lym-
    phoblastic leukemia. Genes Chromosom
    Cancer 49(12):1104–1113

  27. JD MP et al (2001) A physical map of the
    human genome. Nature 409(6822):934–941

  28. Collins FS, Morgan M, Patrinos A (2003)
    The Human Genome Project: lessons from
    large-scale biology. Science 300
    (5617):286–290

  29. Wetterstrand KA (2013) DNA sequencing
    costs: data from the NHGRI Genome


410 Heng Xu and Yang Shu

Free download pdf